Furthermore, a layer of complexity underlying the logical development of GIP/GLP-1R co-agonists grow from numerous studies, indicating that GIPR antagonism may be metabolically beneficial as well
The good news is that most common side effects are manageable and time-limited
The FDA has reported 392 adverse events with compounded semaglutide and 215 with compounded tirzepatide, including multiple hospitalisations from dosing errors

Seek immediate medical attention (call 999 or attend A&E) if you experience: Chest pain or tightness , particularly if radiating to the arm, jaw, or back (possible myocardial infarction) Sudden breathlessness or difficulty breathing , especially with chest pain or coughing up blood (possible pulmonary embolism) Sudden weakness, numbness, or paralysis affecting one side of the body, face drooping, or speech difficulties (possible stroke) Severe leg pain, swelling, warmth, or redness , particularly in one calf (possible deep vein thrombosis) Sudden severe headache unlike any previously experienced Visual disturbances , including sudden loss of vision or double vision Contact your GP or diabetes specialist nurse if you notice: Persistent or worsening leg swelling Unexplained shortness of breath on exertion New or worsening chest discomfort Concerns about your cardiovascular risk factors Patients should also be aware of common side effects of GLP-1 agonists , which are unrelated to blood clots but may cause concern

Complementary treatments : We may recommend additional treatments like WONDERBOD to help maintain muscle mass during weight loss
Some medications like liraglutide, dulaglutide, and semaglutide have proven cardiovascular benefits, along with other benefits such as appetite suppression, weight management, and glycemic control